An exploratory research investigating the appropriate usage and clinical evaluation of compound Monoammonium glycyrrhizinate Glycine DL-Methionine tablet on mild alopecia areata - An exploratory research investigating the appropriate usage and clinical evaluation of compound Monoammmonium glycyrrhizinate Glycine DL-Methionine tablet on mild alopecia areata

Institute of Health Biosciences ,The University of Tokushima Graduate School0 个研究点目标入组 30 人开始时间: 2012年12月28日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Patients who have advanced eczema and/or dermatitis of the scalp 2)Patients in whom three or more hairs are lost in hair pull test 3)Patients who have received oral steroid treatment, inhalation treatment, local steroid injection, or external steroid treatment for scalp within one month before the date of informed consent 4)Patients who have used medical products that claim promotion of hair growth, prevention of hair loss, or hair restoration action within one month before the date of informed consent 5)Patients with a history of allergic reaction to carpronium or glycyrrhizin 6)Patients diagnosed with malignant tumor 7)Patients with serious liver, renal, or cardiac disease 8)Patients who are breast-feeding, pregnant, possibly pregnant, or plan to become pregnant during the study period 9)In addition, patients who are determined as ineligible by the study doctor

发起方

Institute of Health Biosciences ,The University of Tokushima Graduate School